We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Proteomics Products May Reach $1.7 Billion by 2006

By Biotechdaily staff writers
Posted on 20 May 2002
By 2006, total revenues of proteomics-related products are forecast to approach US$1.7 billion, according to a new report from Business Communications Co. More...
(Proteomics: An Assessment of Technology and Commercial Potential, BCI, Inc., Norwalk, CT, USA). Since revenues for selected proteomics products totaled $720 million in 2001, the 2006 forecast would represent an average annual growth rate (AAGR) of just over 18%. This growth is largely due to a boom in scientific discoveries stemming from the human genome project and from advances in high-throughput technologies for protein studies. Other contributing factors are increases in funding for research and an increased interest in drug discovery from pharmaceutical and biotechnology companies.

Today, researchers can analyze protein expression in an entire cell rather than studying individual proteins, notes the report. Newer techniques allow scientists to isolate proteins and identify them more quickly. The development of new technologies for studying proteins has led to a rapid growth in industries supplying instruments and reagents for proteomics studies. In turn, this had made a variety of products easily available from companies eager to compete in the new market.

The market for mass spectroscopy for proteomics represents more than 40% of the total market and is forecast to double in five years, from $300 million in 2001 to $603 million by 2006. The nascent market for protein chips and bioinformatics is expected to rise from $114 million in 2001 to $275 million in 2006. Two-dimensional electrophoresis will see lower growth (11%), while capillary electrophoresis will rise at an AAGR of over 15% during the period.

Factors influencing the growth of the market for drug delivery instruments and services include the continuing investments of national governments into technology-based companies and technology-based not-for-profit research, the push by big pharmaceutical companies to fill their blockbuster pipelines, and efforts by small biotechnology companies to become bigger companies. As all of these groups continue their efforts, says BCC, they will in turn drive the development of new instruments and new technologies.





Related Links:
BCC

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Radial Immunodiffusion Assay
Radial Immunodifusion - C3 ID
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.